These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
260 related items for PubMed ID: 17910427
21. Synthesis and in vitro anti-mycobacterial activity of 5-substituted pyrimidine nucleosides. Johar M, Manning T, Kunimoto DY, Kumar R. Bioorg Med Chem; 2005 Dec 15; 13(24):6663-71. PubMed ID: 16140016 [Abstract] [Full Text] [Related]
22. Synthesis and evaluation of 6-aza-2'-deoxyuridine monophosphate analogs as inhibitors of thymidylate synthases, and as substrates or inhibitors of thymidine monophosphate kinase in Mycobacterium tuberculosis. Kögler M, Busson R, De Jonghe S, Rozenski J, Van Belle K, Louat T, Munier-Lehmann H, Herdewijn P. Chem Biodivers; 2012 Mar 15; 9(3):536-56. PubMed ID: 22422522 [Abstract] [Full Text] [Related]
23. Identification of novel antimycobacterial chemical agents through the in silico multi-conformational structure-based drug screening of a large-scale chemical library. Koseki Y, Kinjo T, Kobayashi M, Aoki S. Eur J Med Chem; 2013 Feb 15; 60():333-9. PubMed ID: 23314046 [Abstract] [Full Text] [Related]
24. Diversity-oriented synthesis of furo[3,2-f]chromanes with antimycobacterial activity. Alvey L, Prado S, Saint-Joanis B, Michel S, Koch M, Cole ST, Tillequin F, Janin YL. Eur J Med Chem; 2009 Jun 15; 44(6):2497-505. PubMed ID: 19232450 [Abstract] [Full Text] [Related]
25. Computer-assisted combinatorial design of bicyclic thymidine analogs as inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase. Frecer V, Seneci P, Miertus S. J Comput Aided Mol Des; 2011 Jan 15; 25(1):31-49. PubMed ID: 21082329 [Abstract] [Full Text] [Related]
26. 3D-Pharmacophore mapping of thymidine-based inhibitors of TMPK as potential antituberculosis agents. Andrade CH, Pasqualoto KF, Ferreira EI, Hopfinger AJ. J Comput Aided Mol Des; 2010 Feb 15; 24(2):157-72. PubMed ID: 20217185 [Abstract] [Full Text] [Related]
27. Synthesis and biological evaluation of inhibitors of thymidine monophosphate kinase from Bacillus anthracis. Byun Y, Vogel SR, Phipps AJ, Carnrot C, Eriksson S, Tiwari R, Tjarks W. Nucleosides Nucleotides Nucleic Acids; 2008 Mar 15; 27(3):244-60. PubMed ID: 18260009 [Abstract] [Full Text] [Related]
33. Elaboration of a proprietary thymidylate kinase inhibitor motif towards anti-tuberculosis agents. Song L, Risseeuw MDP, Froeyen M, Karalic I, Goeman J, Cappoen D, Van der Eycken J, Cos P, Munier-Lehmann H, Van Calenbergh S. Bioorg Med Chem; 2016 Nov 01; 24(21):5172-5182. PubMed ID: 27614917 [Abstract] [Full Text] [Related]
36. Synthesis, modeling and evaluation of 3'-(1-aryl-1H-tetrazol-5-ylamino)-substituted 3'-deoxythymidine derivatives as potent and selective human mitochondrial thymidine kinase inhibitors. Van Poecke S, Negri A, Janssens J, Solaroli N, Karlsson A, Gago F, Balzarini J, Van Calenbergh S. Org Biomol Chem; 2011 Feb 07; 9(3):892-901. PubMed ID: 21127790 [Abstract] [Full Text] [Related]
37. Drug design and identification of potent leads against mycobacterium tuberculosis thymidine monophosphate kinase. Van Calenbergh S, Pochet S, Munier-Lehmann H. Curr Top Med Chem; 2012 Feb 07; 12(7):694-705. PubMed ID: 22283813 [Abstract] [Full Text] [Related]
38. Anti-mycobacterial activity of thymine derivatives bearing boron clusters. Adamska A, Rumijowska-Galewicz A, Ruszczynska A, Studzińska M, Jabłońska A, Paradowska E, Bulska E, Munier-Lehmann H, Dziadek J, Leśnikowski ZJ, Olejniczak AB. Eur J Med Chem; 2016 Oct 04; 121():71-81. PubMed ID: 27236064 [Abstract] [Full Text] [Related]